TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AGC ( (JP:5201) ) has shared an announcement.
AGC Inc. has revised its financial forecasts for the fiscal year ending December 31, 2025, citing a decrease in net sales and operating profit due to production issues in its biopharmaceuticals CDMO business, lower PVC sales prices, and reduced sales volume of semiconductor-related products. The company also anticipates lower profits due to impairment losses from structural reforms at its Boulder and Longmont sites in Colorado, USA. Despite these challenges, the dividends forecast remains unchanged.
The most recent analyst rating on (JP:5201) stock is a Hold with a Yen4700.00 price target. To see the full list of analyst forecasts on AGC stock, see the JP:5201 Stock Forecast page.
More about AGC
AGC Inc. operates in the chemicals industry, providing products and services across various segments including life sciences, chemicals, and electronics. The company focuses on biopharmaceuticals, PVC, and semiconductor-related products.
Average Trading Volume: 1,066,251
Technical Sentiment Signal: Buy
Current Market Cap: Yen950.3B
For detailed information about 5201 stock, go to TipRanks’ Stock Analysis page.